Heeke, Arielle L. http://orcid.org/0000-0001-7809-2564
Xiu, Joanne
Elliott, Andrew
Korn, W. Michael
Lynce, Filipa
Pohlmann, Paula R.
Isaacs, Claudine
Swain, Sandra M.
Vidal, Gregory
Schwartzberg, Lee S.
Tan, Antoinette R.
Article History
Received: 28 May 2020
Accepted: 30 July 2020
First Online: 10 August 2020
Compliance with ethical standards
:
: A.H.: Consultant (Caris Life Sciences). J.X.: Employment (Caris Life Sciences). A.E.: Employment (Caris Life Sciences). M.K.: Consultant (Merck), employment and ownership interest (Caris Life Sciences). F.L.: Fees (Pfizer, ASCO), contracted research (Bristol-Myers Squibb, Calithera, Chugai, Immunomedics, Inivata, Pfizer, Regeneron, Roche/Genentech, Tesaro). P.P.: Consultant (Caris Life Sciences, Heron, Immunonet BioSciences, OncoPlex Diagnostics, Personalized Cancer Therapy, Pfizer, Xcenda), speaker’s bureau (Roche/Genentech), contracted research (Advanced Cancer Therapeutics, Caris Centers of Excellence, Cascadian Therapeutics, Fabre-Kramer, Klus Pharma, Pfizer, Pieris Pharmaceuticals, Roche/Genentech), stock/other ownership (Immunonet BioSciences), patents (No.US 8,501,417; No.US 9,745,377; No.US 9,023,362; No.US 8,486,413). C.I.: Consultant (AstraZeneza, Novartis, Pfizer, PUMA, Roche/Genentech), speaker’s bureau (Roche/Genentech). S.S.: Grants (Pfizer, Roche/Genentech), fees (AstraZeneca, Athenex, Daiichi-Sankyo, Eli Lilly & Company, Genomic Health, Inivata, Pieris Pharmaceuticals, Roche/Genentech, Tocagen), reimbursements (AstraZeneca, Athenex, Bristol-Myers Squibb, Caris Life Sciences, Daiichi-Sankyo, Eli Lilly & Company, Inivata, NanoString Technologies, Novartis, Pieris Pharmaceuticals, Roche/Genentech). G.V.: Fees (AstraZeneca, Eli Lilly, Immunomedics, Novartis, Puma, Pfizer, Roche/Genentech), contracted research (AstraZeneca, Bristol-Myers Squibb, Celcuity, Eli Lilly, GTx Inc, Halozyme, Immunomedics, Merck, Puma, Pfizer, Roche/Genentech, Tesaro), ownership/stocks (Oncodisc). L.S.: Consultant (Amgen, AstraZeneca, Bristol-Myers Squibb, Genomic Health, Merck, Myriad, Napo, Pfizer, Roche/Genentech), contracted research (Amgen, Pfizer). A.T.: Reimbursement (Caris Life Sciences).
: This research study was conducted retrospectively from data obtained for clinical purposes. We consulted extensively with the IRB at the Levine Cancer Institute, Atrium Health, who determined that our study did not need ethical approval.